ANKTIVA Trademark

Trademark Overview


On Wednesday, January 18, 2023, a trademark application was filed for ANKTIVA with the United States Patent and Trademark Office. The USPTO has given the ANKTIVA trademark a serial number of 97759981. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, May 28, 2024. This trademark is owned by Altor BioScience, LLC. The ANKTIVA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immune-oncology, infectious diseases, human diseases, and animal diseases; providing medical information relating to pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, infectious diseases, human diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases, and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections and infectious diseases
anktiva

General Information


Serial Number97759981
Word MarkANKTIVA
Filing DateWednesday, January 18, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements


Goods and ServicesMedical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immune-oncology, infectious diseases, human diseases, and animal diseases; providing medical information relating to pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, infectious diseases, human diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases, and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections and infectious diseases

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 9, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAltor BioScience, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 90232

Party NameAltor BioScience, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 90232

Trademark Events


Event DateEvent Description
Saturday, January 21, 2023NEW APPLICATION ENTERED
Thursday, February 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Saturday, June 17, 2023NON-FINAL ACTION WRITTEN
Saturday, June 17, 2023NON-FINAL ACTION E-MAILED
Saturday, June 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 29, 2024SOU EXTENSION 1 GRANTED
Tuesday, May 28, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU EXTENSION 1 FILED